期刊文献+

霍乱毒素佐剂应用研究进展

Cholera toxin as potent immuno-adjuvant
原文传递
导出
摘要 霍乱毒素(CT)是霍乱弧菌分泌的一种不耐热肠毒素,具有很强的免疫原性和佐剂活性。CT本身有很强的毒副作用,如何既能具备优良的佐剂活性而又没有明显的毒副作用是当前研究的主要目标。CT及其亚单位因其独特的生理功能已被广泛地应用到很多新的免疫与疫苗策略中,已成为当前重要的佐剂之一。 Cholera toxin (CT) is a cholera-secreted, heat-labile enterotoxin with potent adjuvant and immunomodulatory activities. It has been well studied as a mucosal immunity adjuvant. It seems that the adju- vant efffect of CT is tightly associated with its toxicity. How to balance its adjuvant activity and toxicity becomes the major concern in the recent studies. The unique advantage of both CT and its subunits has been extensively employed in new vaccine development strategy.
出处 《国际免疫学杂志》 CAS 北大核心 2010年第5期358-361,共4页 International Journal of Immunology
基金 国家自然科学基金资助项目(30872378)
关键词 霍乱毒素 粘膜免疫 佐剂 Cholera toxin Mucosal immunity Adjuvant
  • 相关文献

参考文献22

  • 1Lycke N,Holmgren J.Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens.Immunology,1986,59(2):301-308.
  • 2Sánchez J,Holmgren J.Cholera toxin structure,gene regulation and athophysiological and immunological aspects.Cell Mol Life Sci,2008,65(9):1347-1360.
  • 3Spangler BD.Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin.Microbiol Rev,1992,56(4):4717-4127.
  • 4Datta SK,Sabet M,Nguyen KP,et al.Mucosal adjuvant activity of cholera todn requires Th17 cells and protects against inhalation anthrax.Proc Natl Acad Sci U S A,2010,107(23):10638-10643.
  • 5Cho HJ,Kim JY,Lee Y,et al.Enhanced humoral and cellular immune responses after sublingual immunization against human papillomavirus 16 L1 protein with adjuvants.Vaccine,2010,28(14):2598-2606.
  • 6Blanchard TG,Lycke N,Czinn SJ,et al.Recombinant cholera B subunit is not an effective adjuvant for oral immunizafion of mice against Helicobacter felis.Immunology,1998,94(1):22-27.
  • 7Kim HJ,Kim JK,Seo SB.Intranasal vaccination with peptides and cholera toxin subunit B as adjuvant to enhance mucosal and systemic immunity to respiratory syncytial virus.Arch Pharm Res,2007,30(3):366-371.
  • 8黄相刚,徐建青(审校),邵一鸣(审校).粘膜免疫相关载体和佐剂研究进展[J].国际免疫学杂志,2006,29(6):361-364. 被引量:6
  • 9Sun JB,Czerkinsky C,Holmgren J.Mucosally induced immunological tolerance,regulatory T cells and the adjuvant effect by cholera toxin B subunit.Scand J Immunol,2010,71(1):1-11.
  • 10Van der Heijden PJ,Bianchi AT,Dol M,et al.Manipulation of intestinal immune responses against ovalbumin by cholera toxin and its B subunit in mice.Immunology,1991,72(1):89-93.

二级参考文献19

  • 1Marinaro M,Riccomi A,Rappuoli R,et al.Mucosal delivery of the human immunodeficiency virus-1 Tat protein in mice elicits systemic neutralizing antibodies,cytotoxic T lymphocytes and mucosal IgA.Vaccine,2003,21 (25 -26):3972-3981.
  • 2Hajishengallis G,Tapping RI,Martin MH,et al.Toil-like receptor 2 mediates cellular activation by the B subunits of type Ⅱ heat-labile enterotoxins.Infect Immun,2005,73 (3):1343-1349.
  • 3Nawar HF,Arce S,Russell MW,et al.Mucosal adjuvant properties of mutant LT-Ⅱa and LT-Ⅱb enterotoxins that exhibit altered ganglioside-binding activities.Infect Immun,2005,73 (3):1330-1342.
  • 4Yoshino N,Lu FX,Fujihashi K,et al.A novel adjuvant for mucosal immunity to HIV-1 gp120 in nonhuman primates.J Immunol,2004,173(11):6850-6857.
  • 5Matoba N,Magerus A,Geyer BC,et al.A mucosally targeted subunit vaccine candidate eliciting HIV-1 transcytosis-blocking Abs.Proc Natl Acad Sci USA,2004,101 (37):13584-13589.
  • 6Aggarwal P,Pandey RM,Seth P.Augmentation of HIV-1 subtype C vaccine constructs induced immune response in mice by CpG motif 1826-ODN.Viral Immunol,2005,18(1):213-223.
  • 7Jiang JQ,Patrick A,Moss RB,et al.CD8^+ T-cell-mediated crossclade protection in the genital tract following intranasal immunization with inactivated human immunodeficiency virus antigen plus CpG oligodeoxynucleotides.J Virol,2005,79(1):393-400.
  • 8Rao M,Matyas GR,Vancott TC,et al.Immunostimulatory CpG motifs induce CTL responses to HIV type Ⅰ oligomeric gp140 envelope protein.Immunol Cell Biol,2004,82(5):523-530.
  • 9Locher CP,Witt SA,Ashlock BM,et al.Evaluation of genetic immunization adjuvants to improve the effectiveness of a human immunodeficiency virus type 2 (HIV-2) envelope DNA vaccine.DNA Cell Biol,2004,23(2):107-110.
  • 10Peters C,Peng X,Douven D,et al.The induction of HIV Gag-specific CD8^+ T Cells in the spleen and gut-associated lymphoid tissue by parenteral or mucosal immunization with recombinant Listeria monocytogenes HIV Gag.J Immunol,2003,170(10):5176-5187.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部